ACXP
ACXP
Last
$1.25
Day
+1.6%
1y
-83.2%
5y
-98.7%
52w
-84.6%
SPY YTD
+13.3%
Sec
—
Earnings
2026-11-1132d
EMA 21
1.32
EMA 50
1.41
EMA 200
2.78
20d high
-12.0%
5y high
-99.3%
5y range
0th
Positions held
Your positionsACXP isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.35
Stop
$1.16
Stop distance
7.2%
Target vs last
+8.0%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-05 · Acurx Pharmaceuticals Takes Its Antibiotics Story Global Through a 12-Month Series with New to The Street
2026-08-21 · Acurx Pharmaceuticals Inc (ACXP) (Q2 2026) Earnings Call Highlights: FDA Signals Potential ...
2026-08-14 · Acurx Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
2026-08-14 · Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update
Price (daily)
Full chart · RSI · MACD · patternsACXP · daily-6.0% over 14 sessions
Close EMA21 EMA50 EMA200